November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...
October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...
October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National ...
October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...
August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...